Qbrelis
NDC 52652-3001, lisinopril, solution, from Azurity Pharmaceuticals, Inc..
- Product NDC
- 52652-3001
- Status
- Listed
- Labeler
- Azurity Pharmaceuticals, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208401
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52652-3001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISINOPRIL1 mg/mL
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52652-3001-1 | 52652300101 | 150 mL in 1 BOTTLE (52652-3001-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9f6e4e57-a489-4b36-b093-b93865d3717cNADAC price for package 52652300101
GET /v1/drugs/nadac/52652300101
Use it
Look up 52652-3001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52652-3001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52652-3001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.